Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Adimmune Corp banner

Adimmune Corp
TWSE:4142

Watchlist Manager
Adimmune Corp Logo
Adimmune Corp
TWSE:4142
Watchlist
Price: 17.75 TWD 2.9% Market Closed
Market Cap: NT$7.6B
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
Adimmune Corp

There are no price targets for Adimmune Corp.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Adimmune Corp Competitors:
Price Targets

Revenue
Forecast

10% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
10% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 1 year is 29%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
133% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
133% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat

The compound annual growth rate for Gross Profit over the next 1 year is 133%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
46%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
46%
Average Beat

What are analyst estimates?

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Adimmune Corp's stock price target?
Not Available

Adimmune Corp does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Adimmune Corp?
Projected CAGR
29%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 1 year is 29%.

What is the Gross Profit forecast for Adimmune Corp?
Projected CAGR
133%

The compound annual growth rate for Gross Profit over the next 1 year is 133%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.